Open Innovation Interview with Brant Cooper and Marco De Polo

Part of what we do at Moves the Needle is to work with large enterprise organizations on corporate innovation strategy and providing education on how to shift away from a traditional management mindset to think and act in a new way.

In this compelling interview, our CEO Brant Cooper spends some time speaking with special guest Marco De Polo, Head Global Strategic Insights & Open Innovation at Roche Diabetes Care, a company that is already working to employ this new mindset.

Marco’s passion and expertise fall into the category of customer opportunity development and lean strategy development, which has helped him create the customer-driven, value creation process currently being utilized inside of Roche.

Discover how Roche is integrating several practices like Jobs to be Done, Design Thinking, and Lean Startup into their process in order to create a system of continuous empathy work and experimentation.

Register now to watch the replay:

Not rendering properly? Catch the replay here.

Questions Answered:

  • How did the Global Strategic Insights and Open Innovation Team at Roche come to be?

  • Does your opportunity assessment and discovery work replace the traditional “market research” function? is interesting.

  • How do you define the areas of opportunity for Roche?

  • How does corporate strategy inform your work?

  • What other elements do you consider? Startups, tech scouting, internal capabilities? Who does that work?

  • What challenges are you facing with regard to innovation?

  • You integrate several practices: Jobs to be Done, Design Thinking with a bit of Lean Startup mixed in. Can you describe what your process look like?

  • What are some key breakthroughs you’ve experienced at Roche using Lean Startup?

  • How do you derive your market segments and personas?

  • How do you integrate the empathy work of Design Thinking into the Jobs to be Done model?

  • What is the difference between traditional market research and what is happening at Roche?

  • How has Roche incorporated empathy work and experimentation as an ongoing process?